ArticleBMC oral health2026
Posterior superior alveolar artery in severely atrophic maxillae prior to lateral sinus augmentation: a retrospective cross-sectional CBCT imaging study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVascular injury to the posterior superior alveolar artery (PSAA) during lateral sinus floor augmentation is a recognized surgical complication, yet data on PSAA anatomy in severely atrophic edentulous maxillae remain scarce. This study aimed to evaluate the prevalence, location patterns, and morphometric characteristics of the PSAA in this specific population using cone-beam computed tomography (CBCT).
methodsPreoperative CBCT scans of 121 patients (242 sinuses) with severely atrophic posterior maxillae (residual ridge height ≤ 5 mm) were retrospectively analyzed. PSAA location was classified as intraosseous (Type I), submembranous (Type II), extraosseous (Type III), or transosseous (Type IV). PSAA diameter and vertical distances to the sinus floor (PSAA-SF) and alveolar crest (PSAA-ALV) were measured. Generalized estimating equations accounted for within-patient correlation from bilateral evaluations.
resultsThe PSAA was identified in 99.17% of sinuses, predominantly Type II (56.67%), followed by Type I (37.50%), Type IV (3.33%), and Type III (2.50%). Mean PSAA diameter was 1.02 ± 0.56 mm, mean PSAA-SF distance 8.89 ± 4.61 mm, and mean residual ridge height 3.55 ± 1.37 mm. Type II location was significantly associated with Schneiderian membrane thickening (p = 0.018).
conclusionsIn severely atrophic edentulous maxillae planned for lateral sinus floor augmentation, the PSAA predominantly follows a submembranous course alongside a clinically critical transosseous variant. Preoperative CBCT assessment of the PSAA is essential to inform individualized surgical planning and minimize hemorrhagic risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.